Singapore markets closed

YiChang HEC ChangJiang Pharmaceutical Co., Ltd. (1558.HK)

HKSE - HKSE Delayed price. Currency in HKD
Add to watchlist
12.660-0.340 (-2.62%)
At close: 04:08PM HKT
Show:
Balance sheet
Cash flow
Annual

Income statement

Currency in CNY. All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
6,294,585
6,294,585
3,744,952
913,788
2,348,113
Cost of revenue
1,308,821
1,308,821
898,878
430,089
351,547
Gross profit
4,985,764
4,985,764
2,846,074
483,699
1,996,566
Operating expenses
Research development
192,287
192,287
129,614
109,673
92,448
Selling general and administrative
1,932,852
1,932,852
1,555,042
880,069
1,471,952
Total operating expenses
2,108,166
2,108,166
1,667,951
924,528
1,553,729
Operating income or loss
2,877,598
2,877,598
1,178,123
-440,829
442,837
Interest expense
227,398
227,398
281,646
243,807
244,206
Income before tax
2,126,771
2,126,771
39,422
-667,184
1,010,434
Income tax expense
270,945
270,945
-9,817
-79,460
173,023
Income from continuing operations
1,855,826
1,855,826
49,239
-587,724
837,411
Net income
1,992,624
1,992,624
76,603
-587,649
839,455
Net income available to common shareholders
1,992,624
1,992,624
76,603
-587,649
839,455
Basic EPS
1.30
2.26
0.09
-0.67
0.95
Diluted EPS
1.30
2.26
0.09
-0.67
0.53
Basic average shares
879,968
879,968
879,968
879,968
881,471
Diluted average shares
879,968
879,968
879,968
879,968
1,105,757